Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011
- PMID: 23780507
- PMCID: PMC11931991
- DOI: 10.1001/jamainternmed.2013.7056
Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011
Abstract
Importance: Clostridium difficile infection (CDI) has been increasingly reported among healthy individuals in the community. Recent data suggest that community-associated CDI represents one-third of all C difficile cases. The epidemiology and potential sources of C difficile in the community are not fully understood.
Objectives: To determine epidemiological and clinical characteristics of community-associated CDI and to explore potential sources of C difficile acquisition in the community.
Design and setting: Active population-based and laboratory-based CDI surveillance in 8 US states.
Participants: Medical records were reviewed and interviews performed to assess outpatient, household, and food exposures among patients with community-associated CDI (ie, toxin or molecular assay positive for C difficile and no overnight stay in a health care facility within 12 weeks). Molecular characterization of C difficile isolates was performed. Outpatient health care exposure in the prior 12 weeks among patients with community-associated CDI was a priori categorized into the following 3 levels: no exposure, low-level exposure (ie, outpatient visit with physician or dentist), or high-level exposure (ie, surgery, dialysis, emergency or urgent care visit, inpatient care with no overnight stay, or health care personnel with direct patient care).
Main outcomes and measures: Prevalence of outpatient health care exposure among patients with community-associated CDI and identification of potential sources of C difficile by level of outpatient health care exposure.
Results: Of 984 patients with community-associated CDI, 353 (35.9%) did not receive antibiotics, 177 (18.0%) had no outpatient health care exposure, and 400 (40.7%) had low-level outpatient health care exposure. Thirty-one percent of patients without antibiotic exposure received proton pump inhibitors. Patients having CDI with no or low-level outpatient health care exposure were more likely to be exposed to infants younger than 1 year (P = .04) and to household members with active CDI (P = .05) compared with those having high-level outpatient health care exposure. No association between food exposure or animal exposure and level of outpatient health care exposure was observed. North American pulsed-field gel electrophoresis (NAP) 1 was the most common (21.7%) strain isolated; NAP7 and NAP8 were uncommon (6.7%).
Conclusions and relevance: Most patients with community-associated CDI had recent outpatient health care exposure, and up to 36% would not be prevented by reduction of antibiotic use only. Our data support evaluation of additional strategies, including further examination of C difficile transmission in outpatient and household settings and reduction of proton pump inhibitor use.
Conflict of interest statement
Figures
Comment in
-
Clostridium difficile leaves the hospital--what's next?JAMA Intern Med. 2013 Jul 22;173(14):1367-8. doi: 10.1001/jamainternmed.2013.7940. JAMA Intern Med. 2013. PMID: 23778358 No abstract available.
-
Clostridium difficile infection in the community: are proton pump inhibitors to blame?World J Gastroenterol. 2013 Oct 28;19(40):6710-3. doi: 10.3748/wjg.v19.i40.6710. World J Gastroenterol. 2013. PMID: 24187445 Free PMC article.
References
-
- Barbut F, Corthier G, Charpak Y, et al. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients: a French multicenter study. Arch Intern Med. 1996;156(13):1449–1454. - PubMed
-
- Bartlett JG. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin Infect Dis. 2008;46(suppl 1):S4–S11. - PubMed
-
- Centers for Disease Control and Prevention (CDC). Severe Clostridium difficile–associated disease in populations previously at low risk: four states, 2005. MMWR Morb Mortal Wkly Rep. 2005;54(47):1201–1205. - PubMed
-
- Centers for Disease Control and Prevention (CDC). Surveillance for community-associated Clostridium difficile: Connecticut, 2006. MMWR Morb Mortal Wkly Rep. 2008;57(13):340–343. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U50CK000198/CK/NCEZID CDC HHS/United States
- U50CK000195/CK/NCEZID CDC HHS/United States
- U50 CK000198/CK/NCEZID CDC HHS/United States
- U50 CK000199/CK/NCEZID CDC HHS/United States
- U50 CK000201/CK/NCEZID CDC HHS/United States
- U50 CK000195/CK/NCEZID CDC HHS/United States
- U50CK000203/CK/NCEZID CDC HHS/United States
- U50 CK000203/CK/NCEZID CDC HHS/United States
- U50 CK000196/CK/NCEZID CDC HHS/United States
- U50CK000196/CK/NCEZID CDC HHS/United States
- U50CK000201/CK/NCEZID CDC HHS/United States
- U50CK000204/CK/NCEZID CDC HHS/United States
- U50 CK000204/CK/NCEZID CDC HHS/United States
- U50 CK000194/CK/NCEZID CDC HHS/United States
- U50CK000194/CK/NCEZID CDC HHS/United States
- CC999999/ImCDC/Intramural CDC HHS/United States
- U50CK000199/CK/NCEZID CDC HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
